ArticleBMC research notes2026
Baseline epigenetic clock measures in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA).
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Baseline epigenetic clock measures in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA).BMC research notes · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesDNA methylation (DNAm) can change dynamically in response to intrinsic or external exposures. Characteristic methylation profiles are associated with accelerated biological ageing and poorer health outcomes. CpG methylation levels for individuals within the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA) were previously generated from baseline blood-derived DNA typed on the Infinium MethylationEPIC array. Harnessing this methylation data, epigenetic clock measures were determined, adjusting for chronological age and white blood cell count (CD8T, CD4T, Natural killer, B-cell, Monocytes and Granulocytes). DATA DESCRIPTION: The NICOLA study was designed to be representative of the Northern Ireland population at Wave 1 and involved the recruitment of 8,283 people from across Northern Ireland. Participants over the age of 50 were recruited. Other household members (spouses/partners) were allowed to take part, even if they were under the age of 50. 2.3% of participants were under the age of 50. Around 50% of participants were aged between 50 and 65, and 10% of participants were over the age of 80 years. This dataset includes epigenetic clock measures for a subset of 1,870 (48% male) participants within the NICOLA cohort, with a mean age of 64.1 ± 9.37 years. The following 10 epigenetic clocks were generated: (± PC)PhenoAge, (± PC)GrimAge, (± PC)Horvath1, (± PC)Hannum, PCDNAmTL and DunedinPACE. ±PC represents the presence or absence of principal component adjustment. This document describes NICOLA's epigenetic clock dataset, which is ~ 2.5Gb in size.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.